Cardiovascular

Organoid electrophysiology is providing pharmaceutical and biotech companies with human-relevant models for testing drug efficacy, modeling diseases, and reducing reliance on animal studies, ultimately accelerating the development of safer and more effective therapeutics.

Wildfire smoke poses a growing public health threat, with harmful pollutants like PM2.5 linked to respiratory and cardiovascular issues. This blog explores the health impacts of wildfire smoke, highlights recent research advancements, and showcases innovative tools like DSI’s inhalation exposure systems and telemetry solutions. Discover how these technologies are helping researchers uncover the mechanisms behind smoke-related health risks and develop interventions to protect vulnerable populations.

The integration of behavioral telemetry and organoid research is transforming neuroscience and biomedical science by linking cellular models with complex biological behaviors.

PTSD affects millions, with varied trauma responses complicating treatment. Advanced research tools, including telemetry and behavioral systems, help uncover physiological and behavioral insights, paving the way for personalized therapies. Studies highlight sex-specific stress adaptations, novel drug targets, and physiological biomarkers, advancing understanding and treatment options for this complex disorder. Continued innovation is key to improving PTSD care.